These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 8652646

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Role of lecithin-cholesterol acyltransferase in the metabolism of oxidized phospholipids in plasma: studies with platelet-activating factor-acetyl hydrolase-deficient plasma.
    Subramanian VS, Goyal J, Miwa M, Sugatami J, Akiyama M, Liu M, Subbaiah PV.
    Biochim Biophys Acta; 1999 Jul 09; 1439(1):95-109. PubMed ID: 10395969
    [Abstract] [Full Text] [Related]

  • 4. A novel lecithin-cholesterol acyltransferase antioxidant activity prevents the formation of oxidized lipids during lipoprotein oxidation.
    Vohl MC, Neville TA, Kumarathasan R, Braschi S, Sparks DL.
    Biochemistry; 1999 May 11; 38(19):5976-81. PubMed ID: 10320323
    [Abstract] [Full Text] [Related]

  • 5. Activation of plasma lysolecithin acyltransferase reaction by apolipoproteins A-I, C-I and E.
    Liu M, Subbaiah PV.
    Biochim Biophys Acta; 1993 Jun 12; 1168(2):144-52. PubMed ID: 8504148
    [Abstract] [Full Text] [Related]

  • 6. Impaired function of lecithin:cholesterol acyltransferase in atherosclerosis-susceptible White Carneau pigeons: possible effects on metabolism of oxidized phospholipids.
    Liu M, St Clair RW, Subbaiah PV.
    J Lipid Res; 1998 Feb 12; 39(2):245-54. PubMed ID: 9507985
    [Abstract] [Full Text] [Related]

  • 7. Minimally oxidized LDL is a potent inhibitor of lecithin:cholesterol acyltransferase activity.
    Bielicki JK, Forte TM, McCall MR.
    J Lipid Res; 1996 May 12; 37(5):1012-21. PubMed ID: 8725153
    [Abstract] [Full Text] [Related]

  • 8. Inhibitory effects of lipid oxidation on the activity of plasma lecithin-cholesterol acyltransferase.
    Kamiyama S, Yamato T, Furukawa Y.
    Biosci Biotechnol Biochem; 1998 May 12; 62(5):941-6. PubMed ID: 9648224
    [Abstract] [Full Text] [Related]

  • 9. Role of sphingomyelin in the regulation of cholesterol esterification in the plasma lipoproteins. Inhibition of lecithin-cholesterol acyltransferase reaction.
    Subbaiah PV, Liu M.
    J Biol Chem; 1993 Sep 25; 268(27):20156-63. PubMed ID: 8376375
    [Abstract] [Full Text] [Related]

  • 10. Role of the interfacial binding domain in the oxidative susceptibility of lecithin:cholesterol acyltransferase.
    Wang K, Subbaiah PV.
    Biochem J; 2002 Aug 01; 365(Pt 3):649-57. PubMed ID: 11966470
    [Abstract] [Full Text] [Related]

  • 11. Novel function of lecithin-cholesterol acyltransferase. Hydrolysis of oxidized polar phospholipids generated during lipoprotein oxidation.
    Goyal J, Wang K, Liu M, Subbaiah PV.
    J Biol Chem; 1997 Jun 27; 272(26):16231-9. PubMed ID: 9195924
    [Abstract] [Full Text] [Related]

  • 12. Lipid oxidation in carriers of lecithin:cholesterol acyltransferase gene mutations.
    Holleboom AG, Daniil G, Fu X, Zhang R, Hovingh GK, Schimmel AW, Kastelein JJ, Stroes ES, Witztum JL, Hutten BA, Tsimikas S, Hazen SL, Chroni A, Kuivenhoven JA.
    Arterioscler Thromb Vasc Biol; 2012 Dec 27; 32(12):3066-75. PubMed ID: 23023370
    [Abstract] [Full Text] [Related]

  • 13. Regulation of plasma cholesterol esterification by sphingomyelin: effect of physiological variations of plasma sphingomyelin on lecithin-cholesterol acyltransferase activity.
    Subbaiah PV, Jiang XC, Belikova NA, Aizezi B, Huang ZH, Reardon CA.
    Biochim Biophys Acta; 2012 Jun 27; 1821(6):908-13. PubMed ID: 22370449
    [Abstract] [Full Text] [Related]

  • 14. Plasma lipids and acyltransferase activities in experimental nephrotic syndrome.
    Sestak TL, Alavi N, Subbaiah PV.
    Kidney Int; 1989 Aug 27; 36(2):240-8. PubMed ID: 2779094
    [Abstract] [Full Text] [Related]

  • 15. Molecular species of phosphatidylcholine in abetalipoproteinemia: effect of lecithin:cholesterol acyltransferase and lysolecithin acyltransferase.
    Banerji B, Subbaiah PV, Gregg RE, Bagdade JD.
    J Lipid Res; 1989 Dec 27; 30(12):1907-16. PubMed ID: 2621418
    [Abstract] [Full Text] [Related]

  • 16. Current Status of Familial LCAT Deficiency in Japan.
    Kuroda M, Bujo H, Yokote K, Murano T, Yamaguchi T, Ogura M, Ikewaki K, Koseki M, Takeuchi Y, Nakatsuka A, Hori M, Matsuki K, Miida T, Yokoyama S, Wada J, Harada-Shiba M.
    J Atheroscler Thromb; 2021 Jul 01; 28(7):679-691. PubMed ID: 33867422
    [Abstract] [Full Text] [Related]

  • 17. Fish eye syndrome: a molecular defect in the lecithin-cholesterol acyltransferase (LCAT) gene associated with normal alpha-LCAT-specific activity. Implications for classification and prognosis.
    Klein HG, Santamarina-Fojo S, Duverger N, Clerc M, Dumon MF, Albers JJ, Marcovina S, Brewer HB.
    J Clin Invest; 1993 Jul 01; 92(1):479-85. PubMed ID: 8326012
    [Abstract] [Full Text] [Related]

  • 18. Role of N-linked glycosylation of lecithin:cholesterol acyltransferase in lipoprotein substrate specificity.
    O K, Hill JS, Pritchard PH.
    Biochim Biophys Acta; 1995 Jan 20; 1254(2):193-7. PubMed ID: 7827124
    [Abstract] [Full Text] [Related]

  • 19. A dual role for lecithin:cholesterol acyltransferase (EC 2.3.1.43) in lipoprotein oxidation.
    McPherson PA, Young IS, McEneny J.
    Free Radic Biol Med; 2007 Dec 01; 43(11):1484-93. PubMed ID: 17964419
    [Abstract] [Full Text] [Related]

  • 20. Recombinant human LCAT normalizes plasma lipoprotein profile in LCAT deficiency.
    Simonelli S, Tinti C, Salvini L, Tinti L, Ossoli A, Vitali C, Sousa V, Orsini G, Nolli ML, Franceschini G, Calabresi L.
    Biologicals; 2013 Nov 01; 41(6):446-9. PubMed ID: 24140107
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.